building of the manufacturing facility: The first Palestinian company to take into consideration GMP guidelines - The British “Orange” Guide.
Amoxicare®, the first product produced by Pharmacare was introduced to the local market.
First international inspection by French experts. Pharmacare declared in the forefront of Palestinian companies in c-GMP guideline implementation.
Established the first computer department as a separate entity in the company, ushering in the IT era into the Palestinian industry.
First computer network in the country was established at Pharmacare
A strategic decision to expand internationally, with continuous local expansion in products and volumes.
First American inspection by a former FDA inspector. PCP obtained an excellent assessment.
First shipment to Russia and Belarus. Pharmacare becomes the first company to export pharmaceuticals from Palestine. Currently Pharmacare is ranked no.12 in the Belarusian market.
Pharmacare signed a joint venture agreement with Grunenthal GmbH of Aachen, Germany giving it 22% of Pharmacare’s share.
Pharmacare inaugurated its state of the art multimillion-dollar manufacturing facility rendering it c-GMP compliant. Thus, Pharmacare is able to adhere to the continuously changing c-GMP guidelines, particularly implementing the zoning system which requires complete separation and independent access into production, packaging, labs and stores.
In the same year, Pharmacare received ISO 9001 and ISO 14000 certifications.
Pharmacare expanded its operations by introducing new therapeutic lines, diversifying the existing ones, and increasing its sales.
Pharmacare signed a supply agreement with Grunenthal GmbH to export Tramadol capsules to Germany. Grunenthal will pack and sell the product in Germany and other EU countries.
Pharmacare acquired the Palestinian Good Manufacturing Practices (GMP) after passing the official audit conducted by Ministry of Health and external experts.
Pharmacare is the 1st Palestinian pharmaceutical company to acquire the European GMP certificate. This great success allowed Pharmacare to enter the European market, which enables further expansion of the company into an international establishment and benefiting the Palestinian economy by increasing the contribution to Palestinian GNP. …
Pharmacare celebrated the first shipment of its medicine to Germany.
Pharmacare Premium project has officially been launched. The project consists of two facilities, one for packaging, testing and batch release of Pharmacare Palestine products and distributing the products for EU countries. The other facility is Oncology (Anti Cancer) product line.
Large amounts of products were exported to the EU. By the end of 2010, about 41% of Pharmacare’s production was exported to European countries.
Pharmacare celebrated the official opening of Pharmacare Premium in Malta as the first Palestinian facility in EU.
Pharmacare successfully renewed its European c-GMP certificate for the coming 3 years. This great success reflects the ability of Pharmacare in maintaining excellence.
Pharmacare Premium acquired the EU GMP approval, and now as a certified facility, it is permitted to start operating as a batch release site.
Pharmacare PLC acquires the Latin American and Brazilian ‘’ANVISA-Granted’’ GMP.
Renewal of EU-GMP
Renewal of the Palestinian GMP.
A new major expansion of Pharmacare’s facilities was initiated following approval of a long-term loan by the French Government. The ribbon cutting ceremony was held in September 2015 in the presence of the then French Minister of Economy and current president, Emanuel Macron. This expansion allows Pharmacare to introduce new production lines…
Palestinian GMP Renewal; Belarus GMP Renewal; EU-GMP Renewal
Building professional relationships with the Polish Pol-Pharma in arrangement of both under-license and marketing authorisation holding agreements permitting the manufacturing of Pol-Pharma products in Palestine and the distribution of the Pharmacare products within a variety of European countries, respectively.
The establishment of the Soft Gel Facility functioning in the manufacturing of soft gel capsule medicinal products.
Renewal of the ISO 9001 and 14001 according to the 2015 guidelines and regulations
Hikma-Care (HC): PCP is inaugurating a joint-venture with Hikma Pharmaceuticals manufacturing Hikma Pharmaceuticals’ products distributed within the West Bank and the Gaza Strip.
The Iraqi Pharmaceutical Industry (IPI): A merging with Pharmacare constituting a 10% share, IPI comprises a manufacturing unit producing facility for conventional products in Iraq.